- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 17:10 | FDA investigates patient deaths after treatment with Sarepta's Duchenne gene therapy Elevidys | ||
| 16:10 | Novo Nordisk questioned over controversial Spanish obesity awareness campaign | ||
| Di | Amarin sells heart pill Vascepa's rights in Europe to Recordati amid restructuring bid | ||
| Di | Cassidy, key in RFK Jr.'s HHS confirmation, calls for deferral of CDC's vaccine meeting | ||
| Di | London calling: The Bloc expands into UK with new office, executive hires | ||
| Di | Craig Romanok follows Omnicom-to-Publicis path, taking up chief commercial officer post at Digitas | ||
| Di | AstraZeneca, Daiichi's Datroway scores its 2nd FDA approval-this time in lung cancer subset | ||
| Mo | UK lays out strategy to become a top 3 life sciences economy by 2035 | ||
| Mo | Reckitt recruits Serena Williams for initiative to support 200 women-led health startups by 2030 | ||
| Mo | FDA's acting CDER head Corrigan-Curay heads for the exit amid period of heavy turnover: reports | ||
| Mo | Hims & Hers stock plunges 30% as Novo Nordisk terminates Wegovy direct sales deal | ||
| Mo | The World Can't Wait: Delivering on the Promise of Biopharma's "Golden Age' Mina Makar, Senior Vice President, Global Cardiovascular, Renal and Metabolism, AstraZeneca | ||
| Mo | AstraZeneca faces new allegations over trial data for blood thinner Brilinta: BMJ | ||
| Mo | Ratio, Ionetix ink separate deals to speed production of in-demand radiopharmaceutical isotopes | ||
| Mo | Roche's bispecific-ADC combo keeps cancer at bay in 2nd shot at 2nd-line large B-cell lymphoma | ||
| Mo | Lilly eyes global approval filings as once-weekly insulin candidate takes clinical victory lap | ||
| Mo | Diabetes and obesity boom will propel Lilly, Novo to front of pharma sales pack by 2030: Evaluate | ||
| Fr | Humor in drug ads? Biogen, 21Grams make it work with gold-winning campaign at Cannes Pharma Lions | ||
| Fr | Europe's CHMP gives thumbs up to ExCellThera's blood cancer cell therapy Zemcelpro | ||
| Fr | Fierce Pharma Asia-AstraZeneca-CSPC deal; FDA's American cell shipping ban; China's trial review acceleration plan | ||
| Fr | Adjusted ACIP agenda omits anticipated votes, revives talks on vaccine ingredient erroneously linked to autism | ||
| 18.06. | Pharma makes Cannes Lions comeback with 'brilliant basics' | ||
| 18.06. | Bavarian Nordic sells FDA priority review voucher from chikungunya vaccine approval for $160M | ||
| 18.06. | Trump administration considers measures to limit DTC drug advertising: Bloomberg | ||
| 18.06. | BioNTech to wind down cell therapy manufacturing in Maryland, lay off 63 as it ends development of CAR-T drug in testicular cancer |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .